Altamira Therapeutics Makes Headway with Bentrio Patent Approval
Hamilton - Altamira Therapeutics Ltd. (OTCQB: CYTOF) recently shared exciting news from the U.S. Patent and Trademark Office regarding their nasal spray product, Bentrio. The company has received a Notice of Allowance for a patent application related to the composition and formulation of this innovative product developed by its affiliate, Altamira Medica AG. Bentrio is tailored specifically to assist those suffering from allergic rhinitis, using a unique and effective formula.
Understanding the Significance of the Patent
The newly allowed patent covers essential claims pertaining to the key ingredients within Bentrio’s distinct formulation, set to bolster Altamira's intellectual property rights in a significant way. As the U.S. represents the largest market for over-the-counter (OTC) treatments for allergic conditions, this patent is crucial for Altamira. The ability to protect the unique formulation enhances their potential to capture market share in the growing demand for allergy relief products.
CEO Thomas Meyer Comments on the Achievements
Thomas Meyer, the founder and CEO of Altamira, expressed pride in reaching this important milestone. He highlighted that Bentrio is formulated without drugs or preservatives, making it a safe option for users. Clinical studies have shown that Bentrio effectively alleviates symptoms such as nasal congestion, sneezing, and itching. Meyer mentioned, “We foresee expanding our accessibility of Bentrio to a more extensive range of markets, particularly in North America, collaborating with established partners in the consumer health sector.”
Bentrio: An Overview of the Product
Bentrio serves as an OTC solution that offers protection against airborne allergens and approved airborne viruses. When applied, it creates a gel layer on the nasal mucosa, effectively acting as a barrier that prevents allergens from interacting with sensitive cells within the nose. This method not only traps airborne particles but also promotes their natural discharge from the system.
Clinical Trials and Results of Bentrio
In a comprehensive set of trials, including the pivotal NASAR study involving 100 patients with seasonal allergic rhinitis, the efficacy of Bentrio was evident. Participants reported significant decreases in their nasal symptom scores when compared with saline solutions, indicating its effectiveness. Furthermore, subjects noted improvements in their overall quality of life and showed better tolerance and reduced reliance on additional relief medications.
About Altamira Therapeutics
Altamira Therapeutics is at the forefront of developing and delivering peptide-based nanoparticle technologies designed for enhancing RNA delivery to various tissues. Their innovative xPhore™ platform underlines their commitment to advancing medical treatments. The company is currently focused on significant preclinical programs, namely AM-401 targeting KRAS driven cancer and AM-411, which addresses rheumatoid arthritis.
Future Plans and Innovations
Beyond Bentrio, Altamira is also exploring partnerships for its auditory health assets while continuing its preclinical developments. Founded in 2003 and headquartered in Hamilton, Bermuda, with key operational sites in Basel, Switzerland, Altamira is positioned as a noteworthy player in biotech focused on effective health solutions.
Frequently Asked Questions
What is Bentrio and how does it work?
Bentrio is a drug-free nasal spray designed to protect against airborne allergens. It forms a protective gel layer in the nasal passages to trap allergens.
What recent achievement has Altamira Therapeutics announced?
Altamira Therapeutics announced that it has received a Notice of Allowance for a patent related to Bentrio from the U.S. Patent and Trademark Office.
How effective is Bentrio based on clinical studies?
Clinical trials have shown Bentrio to significantly reduce symptoms of allergic rhinitis and improve the quality of life of participants compared to saline controls.
Who can benefit from using Bentrio?
Individuals suffering from allergic rhinitis, particularly those sensitive to airborne allergens, can benefit from using Bentrio for relief from their symptoms.
Where can I find more information about Altamira?
Further details about Altamira Therapeutics and its innovations can be found on their official website, where they showcase their product offerings and research endeavors.
